Smoking Cessation Research Paper

Abstract

Problem/Significance: Smoking cessation strategies have significantly reduced tobacco use in the general population but these efforts have not reduced rates in individuals with mental illness.

Individuals diagnosed with a mental illness are more likely to use tobacco products than those without a mental illness. Mortality and morbidity are increased in the mentally ill population compared to the general population not because of the mental illness but because of complications associated with tobacco use.Teaching/Learning Need: Learning needs for individuals with mental illness differ from those of the general population due to the neurocognitive deficits seen in many psychiatric disorders. Thus a tailored approach is necessary. Approach

In addition 16 million Americans are suffering from a tobacco related disease ("Tobacco Use "). Disease and consequently deaths associated with tobacco use are largely preventable and have become a focus of the Healthy People 20/20 initiative. To achieve the overarching goal of reducing illness, disability, and deaths associated with tobacco use, the Healthy People 20/20 initiative is expanding their treatment focus to include cessation programs in the acute care settings. As the initiative specifically mentions at risk populations such as pregnant women and children, the mentally ill population is not mention. This is troubling due to the fact that individuals diagnosed with a mental illness are two times more likely to use tobacco products than those without a mental illness making up 32.4% of all smokers(Lê Cook et al., 2014; Twyman, Bonevski, Paul, & Bryant, 2014). On average individuals suffering from a mental illness die twenty five years before the general population (Prochaska, 2011). These individuals are not dying from their mental illness but rather dying from preventable diseases associated with their tobacco use (Prochaska,

Mental illnesses such as schizophrenia and bipolar have a significant neurocognitive component where significant cognitive deficits are experienced. Neurocognitive deficits lead to poor psychosocial adaptations resulting in difficulty participating in: social events, activities of daily living, social cognition, and intrinsic motivation (Christopher R. Bowie et al., 2010). Individuals diagnosed with schizophrenia and bipolar are substantially more likely to use tobacco and patients with schizophrenia are more likely to have cardiovascular disease associated with their tobacco use as compared to the general population (Mitchell, Vancampfort, De Hert, & Stubbs, 2015) . Mention how many people are suffering from schizophrenia and bipolar somewhere in the